Allmed Medical Products Co.,Ltd (SHE:002950)
China · Delayed Price · Currency is CNY 14.17
-0.29 (-2.01%)
May 8, 2026, 3:04 PM CST
SHE:002950 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Net Income | 279.59 | 257.15 | 368.68 | 110.4 | 406.79 | 431.21 |
Depreciation & Amortization | 242.7 | 242.7 | 232.29 | 227.38 | 193.2 | 147.21 |
Other Amortization | 3.13 | 3.13 | 0.01 | 2.49 | 1.56 | 0.72 |
Loss (Gain) From Sale of Assets | -0.77 | -0.77 | -28.79 | 0.07 | -3.5 | -1.94 |
Asset Writedown & Restructuring Costs | 246.79 | 246.79 | 9.14 | -0.5 | 23.24 | 4.18 |
Loss (Gain) From Sale of Investments | 17.1 | 17.1 | 23.28 | 6.88 | 160.19 | -41.93 |
Provision & Write-off of Bad Debts | - | - | 2.9 | -0.31 | 1.7 | 3.18 |
Other Operating Activities | -132.97 | 33.98 | 34.85 | 143.9 | 173.98 | -15.11 |
Change in Accounts Receivable | -120.22 | -120.22 | -52.27 | 157.56 | -18.06 | 75.81 |
Change in Inventory | -68.6 | -68.6 | 151.35 | 71.09 | -37.14 | -143.41 |
Change in Accounts Payable | 124.82 | 124.82 | -53.16 | -244.71 | 162.03 | -111.76 |
Operating Cash Flow | 572.63 | 717.13 | 711.64 | 423.5 | 1,150 | 374.85 |
Operating Cash Flow Growth | -19.49% | 0.77% | 68.04% | -63.17% | 206.71% | -73.91% |
Capital Expenditures | -286.8 | -260.32 | -157 | -286.48 | -398.05 | -290.7 |
Sale of Property, Plant & Equipment | 2.24 | 0.01 | 9.01 | 0.77 | 3.64 | 7.14 |
Cash Acquisitions | - | - | - | - | -99.07 | -90.83 |
Divestitures | 0.01 | - | - | - | - | - |
Investment in Securities | -687.09 | -15.34 | -1.27 | 139.45 | -475.05 | -98.84 |
Other Investing Activities | 14.91 | 9.56 | 4.6 | -69.21 | -1.99 | 0.11 |
Investing Cash Flow | -956.72 | -266.09 | -144.66 | -215.46 | -970.52 | -473.12 |
Short-Term Debt Issued | - | - | 339 | 180 | 381.91 | - |
Long-Term Debt Issued | - | 594.01 | 616.06 | 1,362 | 2,526 | 3,228 |
Total Debt Issued | 667.54 | 594.01 | 955.06 | 1,542 | 2,908 | 3,228 |
Short-Term Debt Repaid | - | - | -330 | -300.75 | - | - |
Long-Term Debt Repaid | - | -637.35 | -875.8 | -1,525 | -2,976 | -3,184 |
Total Debt Repaid | -627.26 | -637.35 | -1,206 | -1,826 | -2,976 | -3,184 |
Net Debt Issued (Repaid) | 40.27 | -43.34 | -250.74 | -283.52 | -67.51 | 44.41 |
Issuance of Common Stock | - | - | 0.6 | - | - | - |
Repurchase of Common Stock | - | - | -97.89 | - | - | - |
Common Dividends Paid | -51.91 | -52.34 | -44.11 | -65.21 | -163.9 | -577.16 |
Other Financing Activities | 39.59 | 30.51 | 1.99 | 19.92 | -5 | -20 |
Financing Cash Flow | 27.96 | -65.17 | -390.15 | -328.81 | -236.41 | -552.75 |
Foreign Exchange Rate Adjustments | -13.17 | -0.53 | 13.85 | 7.55 | -102.64 | 11.93 |
Net Cash Flow | -369.3 | 385.34 | 190.68 | -113.21 | -159.85 | -639.08 |
Free Cash Flow | 285.83 | 456.81 | 554.64 | 137.02 | 751.68 | 84.16 |
Free Cash Flow Growth | -49.28% | -17.64% | 304.78% | -81.77% | 793.19% | -92.95% |
Free Cash Flow Margin | 7.50% | 12.44% | 16.68% | 4.97% | 17.85% | 2.88% |
Free Cash Flow Per Share | 0.47 | 0.74 | 0.89 | 0.22 | 1.19 | 0.13 |
Cash Income Tax Paid | - | -49.4 | -133.35 | -10.34 | -94.58 | -5.2 |
Levered Free Cash Flow | 192.91 | 342.42 | 375.72 | -366.07 | 996.96 | -70.89 |
Unlevered Free Cash Flow | 192.91 | 342.42 | 391.68 | -346.15 | 1,019 | -60.15 |
Change in Working Capital | -82.95 | -82.95 | 69.3 | -66.82 | 192.57 | -152.67 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.